Cargando…

Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer

The presence of tumor infiltrating lymphocytes (TILs) is associated with a longer overall survival in advanced stage epithelial ovarian cancer. Despite the prognostic impact of TILs, response to checkpoint-inhibitors and antigen-specific active immunotherapy is limited in ovarian cancer. The goal of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baert, Thaïs, Vankerckhoven, Ann, Riva, Matteo, Van Hoylandt, Anaïs, Thirion, Gitte, Holger, Gerhardt, Mathivet, Thomas, Vergote, Ignace, Coosemans, An
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558014/ https://www.ncbi.nlm.nih.gov/pubmed/31214202 http://dx.doi.org/10.3389/fimmu.2019.01273

Ejemplares similares

Opposite Macrophage Polarization in Different Subsets of Ovarian Cancer: Observation from a Pilot Study
por: Vankerckhoven, Ann, et al.
Publicado: (2020)

Type of chemotherapy has substantial effects on the immune system in ovarian cancer
por: Vankerckhoven, Ann, et al.
Publicado: (2021)

Neo-Adjuvant Chemotherapy Reduces, and Surgery Increases Immunosuppression in First-Line Treatment for Ovarian Cancer
por: De Bruyn, Christine, et al.
Publicado: (2021)

The dark side of ID8-Luc2: pitfalls for luciferase tagged murine models for ovarian cancer
por: Baert, Thaïs, et al.
Publicado: (2015)

Ovarian cancer and the immune system
por: Baert, Thaïs, et al.
Publicado: (2017)

Drug Repurposing for Targeting Myeloid-Derived Suppressor-Cell-Generated Immunosuppression in Ovarian Cancer: A Literature Review of Potential Candidates
por: Berckmans, Yani, et al.
Publicado: (2023)

Effect of Particle Carriers for Intraperitoneal Drug Delivery on the Course of Ovarian Cancer and Its Immune Microenvironment in a Mouse Model
por: Wouters, Roxanne, et al.
Publicado: (2022)

Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy
por: Krishnamoorthy, Mithunah, et al.
Publicado: (2021)

A view on dendritic cell immunotherapy in ovarian cancer: how far have we come?
por: Coosemans, A., et al.
Publicado: (2015)

Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer
por: Sprooten, Jenny, et al.
Publicado: (2021)

Depletion of Regulatory T Cells in a Mouse Experimental Glioma Model through Anti-CD25 Treatment Results in the Infiltration of Non-Immunosuppressive Myeloid Cells in the Brain
por: Maes, Wim, et al.
Publicado: (2013)

Preclinical studies performed in appropriate models could help identify optimal timing of combined chemotherapy and immunotherapy
por: Berckmans, Yani, et al.
Publicado: (2023)

Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies
por: Wang, Shifen, et al.
Publicado: (2023)

Immunological parameters as a new lead in the diagnosis of ovarian cancer
por: Baert, T., et al.
Publicado: (2015)

Intraperitoneal alpha therapy with (224)Ra-labeled microparticles combined with chemotherapy in an ovarian cancer mouse model
por: Wouters, Roxanne, et al.
Publicado: (2022)

CT-2A neurospheres-derived high-grade glioma in mice: a new model to address tumor stem cells and immunosuppression
por: Riva, Matteo, et al.
Publicado: (2019)

Dendritic cell-based immunotherapy in ovarian cancer
por: Coosemans, An, et al.
Publicado: (2013)

Long-lived tumor-associated macrophages in glioma
por: Georgieva, Petya B, et al.
Publicado: (2020)

Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
por: Fleming, Viktor, et al.
Publicado: (2018)

Physical activity delays accumulation of immunosuppressive myeloid-derived suppressor cells
por: Garritson, Jacob, et al.
Publicado: (2020)

Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
por: Li, Kai, et al.
Publicado: (2021)

Immunosuppressive Role of Myeloid-Derived Suppressor Cells and Therapeutic Targeting in Lung Cancer
por: Ma, Jie, et al.
Publicado: (2018)

Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
por: Groth, Christopher, et al.
Publicado: (2018)

Glucosamine Interferes With Myelopoiesis and Enhances the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells
por: Lin, Eric Chang-Yi, et al.
Publicado: (2021)

Impaired immunosuppressive role of myeloid-derived suppressor cells in acquired aplastic anemia
por: Dong, Peiyuan, et al.
Publicado: (2022)

Immunological configuration of ovarian carcinoma: features and impact on disease outcome
por: Fucikova, Jitka, et al.
Publicado: (2021)

Polysaccharide from Lentinus edodes Inhibits the Immunosuppressive Function of Myeloid-Derived Suppressor Cells
por: Wu, Hao, et al.
Publicado: (2012)

Lipid Metabolic Pathways Confer the Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor
por: Yan, Dehong, et al.
Publicado: (2019)

RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cells
por: Soong, Ruey-Shyang, et al.
Publicado: (2016)

Myeloid-Derived Suppressor Cells: Major Figures that Shape the Immunosuppressive and Angiogenic Network in Cancer
por: Vetsika, Eleni-Kyriaki, et al.
Publicado: (2019)

Myeloid-Derived Suppressor Cells Are Increased in Lung Transplant Recipients and Regulated by Immunosuppressive Therapy
por: Iglesias-Escudero, María, et al.
Publicado: (2022)

Myeloid-Derived Suppressor Cells Interact with Tumors in Terms of Myelopoiesis, Tumorigenesis and Immunosuppression: Thick as Thieves
por: Sevko, Alexandra, et al.
Publicado: (2012)

Myeloid-derived suppressor cell and macrophage exert distinct angiogenic and immunosuppressive effects in breast cancer
por: Fang, Zhaoxu, et al.
Publicado: (2017)

Modulation of Immunosuppression by Oligonucleotide-Based Molecules and Small Molecules Targeting Myeloid-Derived Suppressor Cells
por: Lim, Jihyun, et al.
Publicado: (2020)

TRAF6 Regulates the Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Tumor-Bearing Host
por: Song, Ge, et al.
Publicado: (2021)

GM-CSF Nitration Is a New Driver of Myeloid Suppressor Cell Activity in Tumors
por: Calì, Bianca, et al.
Publicado: (2021)

ER Stress Regulates Immunosuppressive Function of Myeloid Derived Suppressor Cells in Leprosy that Can Be Overcome in the Presence of IFN-γ
por: Kelly-Scumpia, Kindra M., et al.
Publicado: (2020)

Immunosuppressive activity enhances central carbon metabolism and bioenergetics in myeloid-derived suppressor cells in vitro models
por: Hammami, Ines, et al.
Publicado: (2012)

Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer
por: Dufait, Inès, et al.
Publicado: (2015)

Elevated endoplasmic reticulum stress reinforced immunosuppression in the tumor microenvironment via myeloid-derived suppressor cells
por: Lee, Bo-Ra, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_h8ki51kg93tb635hi5cip0r181